Senior Scientist, Chemistry in Newark - Talents by Vaia

Join to apply for the Senior Scientist, Chemistry role at Protagonist Therapeutics

Join to apply for the Senior Scientist, Chemistry role at Protagonist Therapeutics

Get AI-powered advice on this job and more exclusive features.

Protagonist Therapeutics provided pay range

This range is provided by Protagonist Therapeutics. Your actual pay will be based on your skills and experience — talk with your recruiter to learn more.

Base pay range

$150,000.00/yr - $175,000.00/yr

The discovery chemistry team at Protagonist Therapeutics is seeking a highly motivated Sr. Scientist for a full-time synthetic chemist position. The individual will be responsible for synthesis, purification, and characterization of peptides and other organic molecules within our multi-disciplinary drug discovery team. The individual supports multiple research programs, and possesses excellent verbal and written communication skills. This individual will report to the Director of Chemistry.

Key responsibilities:

• Synthesis of peptides in a highly efficient manner by either solution phase or manual/automated solid phase synthesis to support peptide drug discovery programs
• Provide synthetic chemistry expertise and support cross-functional activities; troubleshoot and solve synthetic problems to improve yields and efficiency
• Lead and/or assist in writing and revising technical documents including synthetic, analytical protocols and data reports
• Analyze, interpret, summarize, communicate results and data to the team through presentations or other formats in a timely manner
• Work with external CROs for outsourcing activities including unnatural amino acids and peptide synthesis
• Organize the lab, maintain instruments, reagents, supplies in daily operations and follow EH&S rules and regulations

Requirements:

• PhD in Chemistry with post-graduate organic synthesis experience 5+ years of post-graduate organic synthesis experience
• Proficiency in organic synthesis; experience in peptide synthesis is a plus
• Proficiency with analytical HPLC, LC-MS, preparative HPLC; experience with automated peptide synthesizer is a plus
• Experience with electronic notebook, Spotfire and other data management and software is a plus
• Excellent time management skills, organizational skills, highly efficient in the lab, adjust work priorities per project needs, and record experiments in an electronic lab notebook in a timely manner
• Ability to develop new skillsets and knowledge is highly desirable
• Work independently with limited guidance and multi-tasking are crucial for success
• Ability to collaborate within the team and cross-function in a dynamic and fast-paced environment
• Strong verbal and written communication skills

The base pay range for this position at commencement of employment is expected to be between $150K and $175K / year; however, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.

Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides, icotrokinra and rusfertide, derived from Protagonist\'s proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA expected in 2025. Icotrokinra (JNJ-2113) is a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor (\"IL-23R\") which is licensed to Janssen Biotech, Inc., a Johnson & Johnson company. Following icotrokinra\'s joint discovery by Protagonist and Johnson & Johnson scientists pursuant to the companies\' IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with Johnson & Johnson assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered into in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage oral drug discovery programs addressing clinically and commercially validated targets, including the IL-17 oral peptide antagonist PN-881, an oral hepcidin program, and an oral obesity program.

The discovery chemistry team at Protagonist Therapeutics is seeking a highly motivated Sr. Scientist for a full-time synthetic chemist position. The individual will be responsible for synthesis, purification, and characterization of peptides and other organic molecules within our multi-disciplinary drug discovery team. The individual supports multiple research programs, and possesses excellent verbal and written communication skills. This individual will report to the Director of Chemistry.

Key responsibilities:

Synthesis of peptides in a highly efficient manner by either solution phase or manual/automated solid phase synthesis to support peptide drug discovery programs

Provide synthetic chemistry expertise and support cross-functional activities; troubleshoot and solve synthetic problems to improve yields and efficiency

Lead and/or assist in writing and revising technical documents including synthetic, analytical protocols and data reports

Analyze, interpret, summarize, communicate results and data to the team through presentations or other formats in a timely manner

Work with external CROs for outsourcing activities including unnatural amino acids and peptide synthesis

Organize the lab, maintain instruments, reagents, supplies in daily operations and follow EH&S rules and regulations

Requirements:

• PhD in Chemistry with post-graduate organic synthesis experience 5+ years of post-graduate organic synthesis experience
• Proficiency in organic synthesis; experience in peptide synthesis is a plus
• Proficiency with analytical HPLC, LC-MS, preparative HPLC; experience with automated peptide synthesizer is a plus
• Experience with electronic notebook, Spotfire and other data management and software is a plus
• Excellent time management skills, organizational skills, highly efficient in the lab, adjust work priorities per project needs, and record experiments in an electronic lab notebook in a timely manner
• Ability to develop new skillsets and knowledge is highly desirable
• Work independently with limited guidance and multi-tasking are crucial for success
• Ability to collaborate within the team and cross-function in a dynamic and fast-paced environment
• Strong verbal and written communication skills

The base pay range for this position at commencement of employment is expected to be between $150K and $175K / year; however, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.

Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides, icotrokinra and rusfertide, derived from Protagonist\'s proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA expected in 2025. Icotrokinra (JNJ-2113) is a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor (\"IL-23R\") which is licensed to Janssen Biotech, Inc., a Johnson & Johnson company. Following icotrokinra\'s joint discovery by Protagonist and Johnson & Johnson scientists pursuant to the companies\' IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with Johnson & Johnson assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered into in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage oral drug discovery programs addressing clinically and commercially validated targets, including the IL-17 oral peptide antagonist PN-881, an oral hepcidin program, and an oral obesity program.

Seniority level

• Seniority level

  Mid-Senior level

Employment type

• Employment type

  Full-time

Job function

• Job function

  Research, Analyst, and Information Technology

• Industries

  Biotechnology

Referrals increase your chances of interviewing at Protagonist Therapeutics by 2x

Sign in to set job alerts for “Chemist” roles.

Fremont, CA $110,000.00-$115,000.00 1 week ago

Hayward, CA $125,000.00-$150,000.00 6 days ago

South San Francisco, CA $28.00-$32.00 4 days ago

Analytical Chemistry Research Associate II-III

Hayward, CA $75,000.00-$105,000.00 1 month ago

San Mateo County, CA $57.00-$57.00 2 weeks ago

Fremont, CA $75,000.00-$85,000.00 2 weeks ago

Fremont, CA $60,000.00-$75,000.00 1 week ago

South San Francisco, CA $100,000.00-$130,000.00 3 days ago

Menlo Park, CA $100,000.00-$150,000.00 2 weeks ago

Fremont, CA $75,000.00-$82,000.00 1 day ago

Hayward, CA $85,000.00-$100,000.00 2 weeks ago

Research Scientist - Computational Chemistry

Oakland, CA $150,000.00-$200,000.00 1 month ago

Scientist — Quality Control Biologics (Clinical Analytical Operations)

Research Assistant, Materials Chemistry (Nanoparticles)

Scientist, Analytical Development and Quality Control

Sunnyvale, CA $87,000.00-$131,000.00 3 weeks ago

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

#J-18808-Ljbffr